Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Adaptive Biotechnologies
Adaptive Biotechnologies
(ADPT)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Mock data
Subscribe for the real data
Revenue by Drug
Marketed Drugs
No data
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Imgatuzumab
recurrence
,
burkitt lymphoma
,
lymphoma
,
non-hodgkin lymphoma
,
follicular lymphoma
,
b-cell lymphoma
,
b-cell lymphoma marginal zone
,
mantle-cell lymphoma
,
large b-cell lymphoma diffuse
,
asthma
,
airway obstruction
Bevifimod
short bowel syndrome
,
syndrome
Muromonab-cd3
recurrence
,
precursor cell lymphoblastic leukemia-lymphoma
,
acute disease
,
philadelphia chromosome
,
lymphoma
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
leukemia
,
lymphoid leukemia
,
non-hodgkin lymphoma
,
follicular lymphoma
,
b-cell chronic lymphocytic leukemia
,
reactive arthritis
,
syndrome
Abt199
myeloid leukemia acute
,
myeloid leukemia
,
myelodysplastic syndromes
,
myelomonocytic leukemia chronic
,
myelomonocytic leukemia juvenile
,
preleukemia
,
syndrome
,
large b-cell lymphoma diffuse
,
b-cell lymphoma
,
multiple myeloma
,
plasma cell neoplasms
,
immunoglobulin light-chain amyloidosis
,
amyloidosis
,
leukemia
,
b-cell chronic lymphocytic leukemia
,
lymphoid leukemia
,
lymphoma
,
mantle-cell lymphoma
Sominex
fibrosis
,
multiple myeloma
,
plasma cell neoplasms
,
rectal neoplasms
,
immunoglobulin g4-related disease
,
colorectal neoplasms
,
adenocarcinoma
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use